First, second,third line drugs for fever

Reading File
Searching the Web

first second third line drugs for fever antipyretics clinical guidelines

Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
I now have comprehensive information from Harrison's (2025) and other key textbooks. Here is the full answer:

Drugs for Fever (Antipyretics)

It is important to note upfront: antipyretics are not formally classified into strict "lines" the way antibiotics are. Instead, they are ranked by preference, safety profile, and clinical context. Harrison's Principles of Internal Medicine (2025) outlines this clearly.

Mechanism of Antipyresis

Fever is driven by prostaglandin E2 (PGE2) synthesis at the hypothalamic thermoregulatory center. All antipyretics work by reducing PGE2 - primarily through inhibition of cyclooxygenase (COX). The antipyretic potency of a drug correlates directly with its degree of brain cyclooxygenase inhibition.

1st Line: Paracetamol (Acetaminophen)

FeatureDetail
Dose (adult)500 mg - 1 g orally every 4-6 hours (max 4 g/day)
Dose (child)10-15 mg/kg every 4-6 hours
MechanismInhibits COX in the CNS (brain P450 oxidizes it to active form); also inhibits COX-3 (CNS-specific); activates CB1/TRPV1 via AM404 metabolite
Why preferredNo anti-inflammatory GI side effects; does not affect platelets; safe in children (no Reye syndrome risk); safe in GI conditions
CautionHepatotoxic in overdose (due to NAPQI accumulation); reduce dose in liver disease
RoutesOral, rectal suppository, IV (for hospitalized patients)
"Acetaminophen is preferred as an antipyretic... In children, acetaminophen or oral ibuprofen must be used because aspirin increases the risk of Reye syndrome."
  • Harrison's Principles of Internal Medicine, 22nd Ed. (2025), p. 180

2nd Line: NSAIDs (Ibuprofen, Naproxen, Diclofenac)

FeatureDetail
Common agentsIbuprofen 400 mg TDS (adults), 5-10 mg/kg/dose in children; Naproxen 500 mg BD; Diclofenac 50 mg TDS
MechanismPeripheral and central COX-1 and COX-2 inhibition; reduce PGE2 systemically; also reduce IL-1-induced IL-6 production
Advantage over paracetamolAlso anti-inflammatory - useful when fever accompanies pain/inflammation (e.g., arthritis, pericarditis)
DisadvantagesGI irritation, peptic ulcers, platelet dysfunction, renal impairment risk, avoid in pregnancy (3rd trimester)
Ibuprofen in childrenAcceptable alternative to paracetamol; both can be alternated in persistent fever
"Oral aspirin and NSAIDs effectively reduce fever but can adversely affect platelets and the gastrointestinal tract. Therefore, acetaminophen is preferred."
  • Harrison's, p. 180
COX-2 selective inhibitors (celecoxib, etoricoxib) are excellent antipyretics with less GI toxicity - useful when GI risk is high.

3rd Line / Special Situations

Aspirin (Acetylsalicylic acid)

  • Effective antipyretic, anti-inflammatory, and analgesic
  • Avoided in children (<12 years) due to risk of Reye syndrome with viral infections
  • Used in adults for specific indications (Kawasaki disease is an exception - aspirin is specifically used)
  • Irreversibly inhibits COX-1 on platelets - avoid when bleeding risk is present

Dipyrone (Metamizole)

  • Effective non-opioid analgesic/antipyretic; used in parts of Europe, Latin America, and South Asia
  • Not available in the UK/USA due to rare risk of agranulocytosis
  • Relieves pain and fever but is not anti-inflammatory (similar profile to paracetamol)

Glucocorticoids (Dexamethasone, Hydrocortisone)

  • Used for refractory fever in specific conditions (autoimmune, autoinflammatory diseases)
  • Dual mechanism: (1) inhibit phospholipase A2 (block arachidonic acid release), (2) block mRNA transcription of pyrogenic cytokines (IL-1, IL-6, TNF)
  • Not routine antipyretics; reserved for specific indications (e.g., Still disease, meningitis adjunct, typhoid with delirium)

Anticytokine therapy (Anakinra, Canakinumab)

  • Targets IL-1 activity
  • Used for autoinflammatory diseases (familial Mediterranean fever, adult Still disease, hyper-IgD syndrome)
  • "Fevers associated with many of these illnesses are dramatically reduced by blocking IL-1 activity with anakinra or canakinumab" - Harrison's, p. 180

Quick Reference Summary

LineDrugBest Use
1stParacetamol (acetaminophen)All ages, general fever, safest overall
2ndNSAIDs (ibuprofen, naproxen)Fever + inflammation; alternate with paracetamol in children for refractory fever
3rdAspirin (adults only), Dipyrone, COX-2 inhibitorsWhen 1st/2nd line not tolerated or specific indication
SpecialGlucocorticoids, Anti-IL-1 agentsAutoimmune/autoinflammatory, hyperpyrexia, CNS involvement

Physical Measures (Adjuncts)

  • Cooling blankets for hyperpyrexia - but should always be combined with antipyretic medication, not used alone
  • Tepid sponging is commonly used but evidence is limited
Sources: Harrison's Principles of Internal Medicine, 22nd Ed. (2025), p. 179-180; Firestein & Kelley's Textbook of Rheumatology; Goodman & Gilman's Pharmacological Basis of Therapeutics

Antipyretic in patient with cld and ckd

Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Excellent - I now have authoritative information from multiple key textbooks. Here is a comprehensive answer:

Antipyretics in CLD + CKD

Managing fever in a patient who has both chronic liver disease (CLD) and chronic kidney disease (CKD) is one of the most challenging drug-choice scenarios in clinical practice because every major antipyretic class carries organ-specific risks.

The Core Problem

Drug ClassCLD RiskCKD Risk
ParacetamolHepatotoxic via NAPQI accumulationGenerally safe (dose interval adjustment in severe CKD)
NSAIDs (ibuprofen, naproxen)GI toxicity + worsens renal dysfunction in cirrhosisReduces GFR, causes AKI, hyperkalemia - CONTRAINDICATED
AspirinGI bleeding risk, platelet dysfunctionAvoid in CKD (fluid retention, worsens GFR)
OpioidsUnpredictable sedation, encephalopathy riskAccumulate in CKD; avoid or reduce dose

Drug of Choice: Paracetamol (with dose reduction)

Paracetamol remains the preferred antipyretic in both CLD and CKD - but with important dose adjustments.

Why paracetamol is still preferred:

  • It does NOT inhibit COX peripherally, so it does not reduce renal prostaglandin synthesis or afferent arteriolar tone - no risk of functional azotemia
  • No GI toxicity
  • No platelet dysfunction
  • Multiple clinical trials have confirmed it is safe for short-term use in liver disease at reduced doses

Mechanism of hepatotoxicity (why dose reduction matters in CLD):

  • Normally, <10% of paracetamol is converted to the toxic metabolite NAPQI via CYP2E1
  • NAPQI is rapidly detoxified by hepatic glutathione
  • In cirrhosis: glutathione stores are depleted + hepatic enzyme function is impaired → NAPQI accumulates → hepatocyte death
  • Additional risk factors: malnutrition, fasting, alcohol use (all common in CLD) - these further deplete glutathione

Dose recommendations:

ConditionMaximum Daily DoseDosing Interval
Normal adult4 g/dayEvery 4-6 hours
Cirrhosis / CLD≤ 2 g/dayEvery 8 hours
CKD (GFR 10-50 ml/min)2-3 g/dayEvery 6 hours
CKD (GFR <10 ml/min / dialysis)2 g/dayEvery 8 hours
Combined CLD + CKD≤ 2 g/dayEvery 8 hours (most conservative)
"Patients with cirrhosis may also be more susceptible, thereby leading to the current recommendation not to exceed 2 g in 24 hours in this population."
  • Goldman-Cecil Medicine, International Edition
"Acetaminophen has traditionally been avoided in patients with any type of liver disease, but there are several trials indicating it to be safe for short-term use, at a reduced dose of 2 grams total per day."
  • Tintinalli's Emergency Medicine

Why NSAIDs Must Be Avoided (Both Conditions)

In CKD:

  • NSAIDs inhibit COX → reduce renal prostaglandin (PGE2, PGI2) synthesis
  • These prostaglandins normally dilate the afferent arteriole to maintain GFR in states of low perfusion
  • NSAID use in CKD → afferent arteriolar constriction → fall in GFR → functional azotemia to frank AKI
  • Risk is dose-dependent, often manifests within the first few weeks
  • Can progress from reversible azotemia to acute tubular necrosis (weeks to resolve, sometimes permanent)
  • Other effects: hyperkalemia, peripheral edema, fluid retention

In CLD (Cirrhosis):

  • Cirrhosis causes effective intravascular volume depletion (splanchnic vasodilation, portal hypertension)
  • Kidney in cirrhosis is already dependent on prostaglandin-mediated vasodilation to maintain perfusion
  • NSAIDs in this setting = hepatorenal syndrome precipitant
  • Rheumatology textbook explicitly lists cirrhosis as a setting where NSAIDs are relatively contraindicated alongside nephrotic syndrome and heart failure
"NSAIDs are relatively contraindicated in settings of preexisting renal hypoperfusion... such as nephrotic syndrome, congestive heart failure, cirrhosis, and protein-wasting enteropathies."
  • Rheumatology (Firestein), 2022

Why Aspirin is Avoided

  • Platelet dysfunction + risk of variceal bleeding in cirrhosis (portal hypertension patients have high bleeding risk)
  • GI ulceration
  • Causes fluid retention and further reduces GFR in CKD

Practical Algorithm for CLD + CKD Patient with Fever

Fever in CLD + CKD patient
        │
        ▼
AVOID: NSAIDs, Aspirin
        │
        ▼
Use PARACETAMOL
  - Max 2 g/day
  - Dose every 8 hours (500 mg q8h)
  - Short-term use preferred
  - Avoid if: active alcohol use, severe malnutrition, decompensated cirrhosis (Child C)
        │
        ▼
If decompensated cirrhosis (Child C) or GFR <10:
  - Use LOWEST effective dose (500 mg q8h or q12h)
  - Monitor LFTs, renal function
  - Consider physical cooling methods as adjunct
        │
        ▼
Refractory/high fever in specific disease (e.g., autoinflammatory):
  - Short-course GLUCOCORTICOIDS (only if specific indication)
  - Avoid opioids; if unavoidable - FENTANYL at reduced dose
    (no active toxic metabolites, unlike morphine/codeine)

Key Points to Remember

  1. Paracetamol ≤ 2 g/day is the drug of choice - not contraindicated, just dose-reduced
  2. NSAIDs are contraindicated in both CLD and CKD - they precipitate AKI and hepatorenal syndrome
  3. Aspirin avoided due to bleeding risk in cirrhosis
  4. Opioids avoided in CLD (encephalopathy risk); if unavoidable, fentanyl is safest (no active toxic metabolites)
  5. Treat the underlying cause of fever (antibiotics for SBP, antivirals, etc.) - antipyretics are adjunctive
Sources: Tintinalli's Emergency Medicine; Goldman-Cecil Medicine; Firestein & Kelley's Textbook of Rheumatology (2022); Harrison's Principles of Internal Medicine 22nd Ed. (2025)

Time taken to increase the sugar leve if tea drink(grbs-89)

Finding Sources
Finding Sources
Reading File
Finding Sources
I have the key information from Goldman-Cecil Medicine. Here is the complete clinical answer:

GRBS 89 mg/dL + Sweetened Tea: Time to Rise

First - Is GRBS 89 Truly Hypoglycemia?

ThresholdValue
Normal fasting glucose70-100 mg/dL
Hypoglycemia threshold< 70 mg/dL
Alert/action threshold≤ 70 mg/dL
GRBS 89 mg/dLLow-normal - technically NOT hypoglycemia
A GRBS of 89 mg/dL is not hypoglycemic - it is within the normal fasting range. However, in a symptomatic patient (sweating, tremors, palpitations) or if trending downward, a clinician may choose to give oral sugar as a precaution.

Time for Sweetened Tea to Raise Blood Sugar

Physiology of glucose absorption after oral intake:

PhaseTimeWhat Happens
Gastric emptying0-15 minSugar (sucrose/glucose) enters the small intestine
Intestinal absorption10-20 minGlucose absorbed via SGLT1 (active) and GLUT2 (passive) in jejunum
Blood glucose rise begins~15 minutesDetectable rise in capillary blood glucose
Peak glucose rise30-45 minutesMaximum effect of oral sugar drink

The "15-15 Rule" (Standard Clinical Protocol):

"If adults are conscious and able to swallow, the best approach is 15 to 20 g of rapid-acting carbohydrate... If the capillary glucose remains less than 72 mg/dL, oral treatment can be repeated up to three times, 15 minutes apart."
  • Goldman-Cecil Medicine, International Edition
This rule is derived from the fact that blood glucose rises measurably within 15 minutes of oral glucose/sugar ingestion. This is why the standard recommendation is:
  • Give 15-20 g of fast-acting carbohydrate
  • Recheck GRBS after 15 minutes
  • Repeat if still low

How Much Sugar Does Tea Contain?

PreparationSugar contentGlucose equivalent
1 teaspoon sugar in tea~4 g sucrose~2 g glucose + 2 g fructose
3-4 heaped teaspoons sugar dissolved in water~15-20 gThe recommended treatment dose
Standard Indian tea with 2 tsp sugar~8 g sucroseSub-therapeutic for hypoglycemia treatment
For therapeutic purposes (treating hypoglycemia), tea needs 3-4 heaped teaspoons of sugar - a regular cup of "mildly sweet" tea alone is inadequate.

Why Fat Slows the Response

"Foods with a high fat content (e.g., chocolate) should be avoided because they delay gastric emptying, thereby slowing the absorption of carbohydrate."
  • Goldman-Cecil Medicine
Plain sweetened tea (no milk fat in large amounts) is actually preferable to sugary snacks like biscuits or chocolate because:
  • No fat to delay gastric emptying
  • Sugar dissolved in hot water absorbs faster than solid foods
  • Effect begins in ~15 minutes

Practical Summary

QuestionAnswer
GRBS 89 - is treatment needed?Not for hypoglycemia (>70). Observe if symptomatic
Time for tea to raise glucose~15 minutes to begin rising
Peak effect30-45 minutes
When to recheck GRBS15 minutes after oral intake
Adequate sugar dose15-20 g (3-4 teaspoons dissolved in water/tea)
If still low after 3 attempts?IV dextrose (D50W) or IM glucagon
After glucose corrects: always follow with a long-acting carbohydrate (bread, rice, milk) to prevent recurrence - sugar in tea provides a short-lived spike without sustained glycemia.
Source: Goldman-Cecil Medicine, International Edition
This is a shared conversation. Sign in to Orris to start your own chat.